Literature DB >> 22114341

Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b.

Jayna Raghwani1, Xiomara V Thomas, Sylvie M Koekkoek, Janke Schinkel, Richard Molenkamp, Thijs J van de Laar, Yutaka Takebe, Yasuhito Tanaka, Masashi Mizokami, Andrew Rambaut, Oliver G Pybus.   

Abstract

Since its initial identification in St. Petersburg, Russia, the recombinant hepatitis C virus (HCV) 2k/1b has been isolated from several countries throughout Eurasia. The 2k/1b strain is the only recombinant HCV to have spread widely, raising questions about the epidemiological background in which it first appeared. In order to further understand the circumstances by which HCV recombinants might be formed and spread, we estimated the date of the recombination event that generated the 2k/1b strain using a Bayesian phylogenetic approach. Our study incorporates newly isolated 2k/1b strains from Amsterdam, The Netherlands, and has employed a hierarchical Bayesian framework to combine information from different genomic regions. We estimate that 2k/1b originated sometime between 1923 and 1956, substantially before the first detection of the strain in 1999. The timescale and the geographic spread of 2k/1b suggest that it originated in the former Soviet Union at about the time that the world's first centralized national blood transfusion and storage service was being established. We also reconstructed the epidemic history of 2k/1b using coalescent theory-based methods, matching patterns previously reported for other epidemic HCV subtypes. This study demonstrates the practicality of jointly estimating dates of recombination from flanking regions of the breakpoint and further illustrates that rare genetic-exchange events can be particularly informative about the underlying epidemiological processes.

Entities:  

Mesh:

Year:  2011        PMID: 22114341      PMCID: PMC3302385          DOI: 10.1128/JVI.06184-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

Review 1.  Hepatitis C virus and blood transfusion: past and present risks.

Authors:  C L van der Poel
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  The epidemic behavior of the hepatitis C virus.

Authors:  O G Pybus; M A Charleston; S Gupta; A Rambaut; E C Holmes; P H Harvey
Journal:  Science       Date:  2001-06-22       Impact factor: 47.728

4.  Hepatitis C virus mixed genotype infection in patients on haemodialysis.

Authors:  K P Qian; S N Natov; B J Pereira; J Y Lau
Journal:  J Viral Hepat       Date:  2000-03       Impact factor: 3.728

5.  Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan.

Authors:  Fuat Kurbanov; Yasuhito Tanaka; Dildora Avazova; Anis Khan; Fuminaka Sugauchi; Nataliya Kan; Dinara Kurbanova-Khudayberganova; Aziza Khikmatullaeva; Erkin Musabaev; Masashi Mizokami
Journal:  Hepatol Res       Date:  2007-11-21       Impact factor: 4.288

6.  Nomenclature and numbering of the hepatitis C virus.

Authors:  Carla Kuiken; Peter Simmonds
Journal:  Methods Mol Biol       Date:  2009

7.  Analysis of the origin and evolutionary history of HIV-1 CRF28_BF and CRF29_BF reveals a decreasing prevalence in the AIDS epidemic of Brazil.

Authors:  Natalia Ristic; Jean Zukurov; Wagner Alkmim; Ricardo Sobhie Diaz; Luiz Mario Janini; Mario P S Chin
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

8.  Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.

Authors:  Rita Almeida Calado; Maria Raquel Rocha; Ricardo Parreira; João Piedade; Teresa Venenno; Aida Esteves
Journal:  J Med Virol       Date:  2011-04       Impact factor: 2.327

Review 9.  Genetic diversity and evolution of hepatitis C virus--15 years on.

Authors:  Peter Simmonds
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

10.  Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.

Authors:  Thijs J W van de Laar; Richard Molenkamp; Charlotte van den Berg; Janke Schinkel; Marcel G H M Beld; Maria Prins; Roel A Coutinho; Sylvia M Bruisten
Journal:  J Hepatol       Date:  2009-06-18       Impact factor: 25.083

View more
  20 in total

1.  High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment.

Authors:  Marine Karchava; Jesper Waldenström; Monica Parker; Renee Hallack; Lali Sharvadze; Lana Gatserelia; Nikoloz Chkhartishvili; Natia Dvali; Lela Dzigua; Ekaterine Dolmazashvili; Helene Norder; Tengiz Tsertsvadze
Journal:  Hepatol Res       Date:  2015-03-24       Impact factor: 4.288

2.  Next-Generation Sequencing: a Diagnostic One-Stop Shop for Hepatitis C?

Authors:  Mario Poljak
Journal:  J Clin Microbiol       Date:  2016-08-10       Impact factor: 5.948

3.  Whole genome pyrosequencing of rare hepatitis C virus genotypes enhances subtype classification and identification of naturally occurring drug resistance variants.

Authors:  Ruchi M Newman; Thomas Kuntzen; Brian Weiner; Andrew Berical; Patrick Charlebois; Carla Kuiken; Donald G Murphy; Peter Simmonds; Phil Bennett; Niall J Lennon; Bruce W Birren; Michael C Zody; Todd M Allen; Matthew R Henn
Journal:  J Infect Dis       Date:  2012-11-06       Impact factor: 5.226

4.  Estimating divergence dates and substitution rates in the Drosophila phylogeny.

Authors:  Darren J Obbard; John Maclennan; Kang-Wook Kim; Andrew Rambaut; Patrick M O'Grady; Francis M Jiggins
Journal:  Mol Biol Evol       Date:  2012-06-07       Impact factor: 16.240

5.  Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing.

Authors:  James C Iles; Richard Njouom; Yacouba Foupouapouognigni; David Bonsall; Rory Bowden; Amy Trebes; Paolo Piazza; Ellie Barnes; Jacques Pépin; Paul Klenerman; Oliver G Pybus
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

6.  Molecular detection and genomic characterization of diverse hepaciviruses in African rodents.

Authors:  Magda Bletsa; Bram Vrancken; Sophie Gryseels; Ine Boonen; Antonios Fikatas; Yiqiao Li; Anne Laudisoit; Sebastian Lequime; Josef Bryja; Rhodes Makundi; Yonas Meheretu; Benjamin Dudu Akaibe; Sylvestre Gambalemoke Mbalitini; Frederik Van de Perre; Natalie Van Houtte; Jana Těšíková; Elke Wollants; Marc Van Ranst; Oliver G Pybus; Jan Felix Drexler; Erik Verheyen; Herwig Leirs; Joelle Gouy de Bellocq; Philippe Lemey
Journal:  Virus Evol       Date:  2021-04-12

7.  Recombination in hepatitis C virus: identification of four novel naturally occurring inter-subtype recombinants.

Authors:  Weifeng Shi; Ines T Freitas; Chaodong Zhu; Wei Zheng; William W Hall; Desmond G Higgins
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

8.  Evidence that hepatitis C virus genome partly controls infection outcome.

Authors:  Matthew Hartfield; Rowena Bull; Peter A White; Andrew Lloyd; Fabio Luciani; Samuel Alizon
Journal:  Evol Appl       Date:  2014-03-26       Impact factor: 5.183

9.  Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC.

Authors:  Yi Feng; Yutaka Takebe; Huamian Wei; Xiang He; Jenny H Hsi; Zhenpeng Li; Hui Xing; Yuhua Ruan; Yao Yang; Fan Li; Jing Wei; Xingguang Li; Yiming Shao
Journal:  Sci Rep       Date:  2016-01-14       Impact factor: 4.379

10.  Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.

Authors:  Wim Schuermans; Hans Orlent; Isabelle Desombere; Patrick Descheemaeker; Hans Van Vlierberghe; Anja Geerts; Xavier Verhelst; Marijke Reynders; Elizaveta Padalko
Journal:  Int J Mol Sci       Date:  2016-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.